Jinling Pharmaceutical Co Ltd Cash Flow Quality Index
Jinling Pharmaceutical Co Ltd cash flow quality index. Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Quality Index of 3.68x as of September 2025. Operating cash flow of CN¥74.01 Million exceeds net income of CN¥20.12 Million, indicating high earnings quality where cash backs reported profits. See Jinling Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jinling Pharmaceutical Co Ltd (1999–2024)
Cash flow quality index of Jinling Pharmaceutical Co Ltd from 1999 to 2024. Historical Cash Flow Quality Index for Jinling Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jinling Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jinling Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2024)
Jinling Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2024. Year-by-year earnings quality comparison for Jinling Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jinling Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 8.59x | CN¥154.19 Million | CN¥17.95 Million | ▲ +438.5% |
| 2023 | 1.59x | CN¥158.92 Million | CN¥99.65 Million | ▼ -30.3% |
| 2022 | 2.29x | CN¥260.59 Million | CN¥113.87 Million | ▲ +19.9% |
| 2021 | 1.91x | CN¥292.03 Million | CN¥152.94 Million | ▼ -42.6% |
| 2020 | 3.33x | CN¥311.46 Million | CN¥93.66 Million | ▲ +31.1% |
| 2019 | 2.54x | CN¥465.85 Million | CN¥183.68 Million | ▲ +68.9% |
| 2018 | 1.50x | CN¥433.83 Million | CN¥288.88 Million | ▼ -41.4% |
| 2017 | 2.56x | CN¥443.11 Million | CN¥172.93 Million | ▲ +492.5% |
| 2016 | 0.43x | CN¥96.15 Million | CN¥222.33 Million | ▼ -46.7% |
| 2015 | 0.81x | CN¥212.45 Million | CN¥262.00 Million | ▼ -33.7% |
| 2014 | 1.22x | CN¥299.89 Million | CN¥245.16 Million | ▼ -14.3% |
| 2013 | 1.43x | CN¥271.21 Million | CN¥190.06 Million | ▲ +10.2% |
| 2012 | 1.29x | CN¥232.12 Million | CN¥179.26 Million | ▲ +57.8% |
| 2011 | 0.82x | CN¥172.82 Million | CN¥210.62 Million | ▲ +7.4% |
| 2010 | 0.76x | CN¥177.81 Million | CN¥232.70 Million | ▲ +7.1% |
| 2009 | 0.71x | CN¥188.41 Million | CN¥264.01 Million | ▼ -77.9% |
| 2008 | 3.23x | CN¥305.26 Million | CN¥94.37 Million | ▲ +880.0% |
| 2007 | 0.33x | CN¥118.06 Million | CN¥357.67 Million | ▼ -44.4% |
| 2006 | 0.59x | CN¥138.50 Million | CN¥233.47 Million | ▼ -4.7% |
| 2005 | 0.62x | CN¥109.29 Million | CN¥175.52 Million | ▼ -54.9% |
| 2004 | 1.38x | CN¥159.81 Million | CN¥115.83 Million | ▲ +24.7% |
| 2003 | 1.11x | CN¥161.86 Million | CN¥146.23 Million | ▲ +19.3% |
| 2002 | 0.93x | CN¥130.36 Million | CN¥140.52 Million | ▲ +17.2% |
| 2001 | 0.79x | CN¥92.49 Million | CN¥116.81 Million | ▼ -59.2% |
| 2000 | 1.94x | CN¥231.31 Million | CN¥119.24 Million | ▲ +451.0% |
| 1999 | 0.35x | CN¥39.77 Million | CN¥112.96 Million | — |